Alternate sources and substitutes for therapeutic blood components

R. A. Kahn, R. W. Allen, J. Baldassare

    Research output: Contribution to journalReview article

    23 Citations (Scopus)

    Abstract

    With the rapid advancement of technology, blood substitutes and alternate sources of therapeutic blood components are likely to become available, although not for a number of years. Within five to eight years, at least some plasma derivatives probably will be replaced by alternate sources using recombinant DNA technology; substitutes for RBCs and platelets will be much more difficult to develop. Availability of these products will have far-reaching effects on our health care system and it is probably not too soon to anticipate the effects and plan for the consequences.

    Original languageEnglish
    Pages (from-to)1-12
    Number of pages12
    JournalBlood
    Volume66
    Issue number1
    StatePublished - 1 Dec 1985

    Fingerprint

    Blood Substitutes
    Genetic engineering
    Platelets
    Health care
    Blood
    Availability
    Technology
    Derivatives
    Plasmas
    Recombinant DNA
    Blood Platelets
    Delivery of Health Care
    Therapeutics

    Cite this

    Kahn, R. A. ; Allen, R. W. ; Baldassare, J. / Alternate sources and substitutes for therapeutic blood components. In: Blood. 1985 ; Vol. 66, No. 1. pp. 1-12.
    @article{1da69ab33000494594419afbf314550e,
    title = "Alternate sources and substitutes for therapeutic blood components",
    abstract = "With the rapid advancement of technology, blood substitutes and alternate sources of therapeutic blood components are likely to become available, although not for a number of years. Within five to eight years, at least some plasma derivatives probably will be replaced by alternate sources using recombinant DNA technology; substitutes for RBCs and platelets will be much more difficult to develop. Availability of these products will have far-reaching effects on our health care system and it is probably not too soon to anticipate the effects and plan for the consequences.",
    author = "Kahn, {R. A.} and Allen, {R. W.} and J. Baldassare",
    year = "1985",
    month = "12",
    day = "1",
    language = "English",
    volume = "66",
    pages = "1--12",
    journal = "Blood",
    issn = "0006-4971",
    publisher = "American Society of Hematology",
    number = "1",

    }

    Kahn, RA, Allen, RW & Baldassare, J 1985, 'Alternate sources and substitutes for therapeutic blood components', Blood, vol. 66, no. 1, pp. 1-12.

    Alternate sources and substitutes for therapeutic blood components. / Kahn, R. A.; Allen, R. W.; Baldassare, J.

    In: Blood, Vol. 66, No. 1, 01.12.1985, p. 1-12.

    Research output: Contribution to journalReview article

    TY - JOUR

    T1 - Alternate sources and substitutes for therapeutic blood components

    AU - Kahn, R. A.

    AU - Allen, R. W.

    AU - Baldassare, J.

    PY - 1985/12/1

    Y1 - 1985/12/1

    N2 - With the rapid advancement of technology, blood substitutes and alternate sources of therapeutic blood components are likely to become available, although not for a number of years. Within five to eight years, at least some plasma derivatives probably will be replaced by alternate sources using recombinant DNA technology; substitutes for RBCs and platelets will be much more difficult to develop. Availability of these products will have far-reaching effects on our health care system and it is probably not too soon to anticipate the effects and plan for the consequences.

    AB - With the rapid advancement of technology, blood substitutes and alternate sources of therapeutic blood components are likely to become available, although not for a number of years. Within five to eight years, at least some plasma derivatives probably will be replaced by alternate sources using recombinant DNA technology; substitutes for RBCs and platelets will be much more difficult to develop. Availability of these products will have far-reaching effects on our health care system and it is probably not too soon to anticipate the effects and plan for the consequences.

    UR - http://www.scopus.com/inward/record.url?scp=0022262106&partnerID=8YFLogxK

    M3 - Review article

    C2 - 2860936

    AN - SCOPUS:0022262106

    VL - 66

    SP - 1

    EP - 12

    JO - Blood

    JF - Blood

    SN - 0006-4971

    IS - 1

    ER -